Bioequivalence of Two Different Drug Product Batches of Dabigatran Etexilate Following Oral Administration in Healthy Male and Female Volunteers

NCT02171013 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

66

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Dabigatran polymorph I (≈ 83%) and polymorph II (≈17%)
DRUG: Dabigatran polymorph I

Sponsor

Boehringer Ingelheim